Evidence map›Paper›PMID 23070557›Full record

ReviewNature reviews. Microbiology2012

Modulation of innate immunity by Toxoplasma gondii virulence effectors.

Christopher A Hunter, L David Sibley

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 313 papers.

0numbers the graph read from it
0cells of the map it votes in
313citing papers in PubMed
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

313 citing papers in PubMed, 546 citations in OpenAlex.

  1. Live-attenuatedVirulence · 2026
    Article
  2. Article
  3. Photodynamic Therapy for Toxoplasma gondii Infections Using Rose Bengal.Luminescence : the journal of biological and chemical luminescence · 2026
    Article
  4. Article
  5. Article
  6. Advances and Translational Challenges inVeterinary sciences · 2026
    Review
  7. Article
  8. Article
  9. A Suite of EightbioRxiv : the preprint server for biology · 2026
    Article
  10. Review
  11. Transboundary and emerging diseases · 2026
    Article
  12. Review
  13. Frontiers in cellular and infection microbiology · 2026
    Article
  14. Article
  15. Bioactive materials · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

253 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Christopher A HunterDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104, USA. chunter@vet.upenn.edu
L David Sibley
University of Pennsylvania · USWashington University in St. Louis · US

Funding

MOLECULAR BASIS OF TOXOPLASMOSIS IN AIDS PATIENTSR01AI036629 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 1994 to 2013
$5.3M
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMAR01AI082423 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2009 to 2015
$2.9M
Host-parasite interactions during toxoplasmosisR21AI104998 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HUNTER, CHRISTOPHER A · 2013 to 2014
$440k
NIAID NIH HHS R01 AI036629NIAID NIH HHS R01 AI082423NIAID NIH HHS R21 AI104998
6 · The paper itself

Abstract

Toxoplasma gondii is a common parasite of animals and humans and can cause serious opportunistic infections. However, the majority of infections are asymptomatic, possibly because the organism has co-evolved with its many vertebrate hosts and has developed multiple strategies to persist asymptomatically for the lifetime of the host. Over the past two decades, infection studies in the mouse, combined with forward-genetics approaches aimed at unravelling the molecular basis of infection, have revealed that T. gondii virulence is mediated, in part, by secretion of effector proteins into the host cell during invasion. Here, we review recent advances that illustrate how these virulence factors disarm innate immunity and promote survival of the parasite.

Indexed as

Host-Parasite InteractionsImmunity, InnateAnimalsAnimals, DomesticCatsHumansImmune EvasionMiceProtein-Tyrosine KinasesProtozoan ProteinsSignal TransductionToxoplasmaToxoplasmosisToxoplasmosis, AnimalVirulence FactorsProtein-Tyrosine KinasesProtozoan ProteinsRop16 protein, Toxoplasma gondiiVirulence Factors

Identifiers

PMID23070557
PMCPMC3689224
OpenAlexW2031029755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.